Stocks
Novo Nordisk (NVO) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.14 | 0.14 | 0.03 | 0.03 | -0.03 | 0.14 | |||
| Changes by years, y/y, % | -451% | -3% | -79% | -6% | -206% | -37.3% | |||
Novo Nordisk. Debt/EBITDA
Novo Nordisk. Debt/EBITDA, changes, %
Novo Nordisk (NVO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 0.00 | -0.13 | -0.22 | -0.03 | 0.14 | 0.14 | ||
| Changes by years, y/y, % | +31% | +51% | -197% | -629% | ||||
| Changes by quarters, q/q, % | -100% | +67% | -87% | -612% | ||||
